相似文献/References:
[1]尚思慧,林琬君.左炔诺孕酮宫内缓释系统的非避孕应用[J].中国计划生育和妇产科,2011,(06):0.
SHANG Si-hui,LIN Wan-jun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(02):0.
[2]姜桂芳.曼月乐预防子宫内膜息肉宫腔镜下切除术后复发的临床分析[J].中国计划生育和妇产科,2012,(02):0.
JIANG Gui-Fang.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(02):0.
[3]从蓉俊*,孔彩霞,符圆圆,等.曼月乐和达芙通预防子宫内膜息肉切除术后复发的效果比较[J].中国计划生育和妇产科,2017,(3):39.
CONG Rong-jun*,KONG Cai-xia,FU Yuan- yuan,et al.Comparison of the effects of Mirena and Duphaston on prevention of recurrence after transcervical resection of polyp[J].Chinese Journal of Family Planning & Gynecotokology,2017,(02):39.
[4]赵楠,张萍*.子宫内膜不典型增生患者保留生育功能的相关研究进展[J].中国计划生育和妇产科,2017,(9):15.
[5]苑文贺,史惠蓉*.子宫内膜复杂性不典型增生及早期子宫内膜癌患者保留生育功能的预后分析[J].中国计划生育和妇产科,2018,(1):23.
YUAN Wen-he,SHI Hui-rong*.Prognosis analysis of fertility maintenance in women with complex endometrial hyperplasia or endometrial cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(02):23.
[6]王洁.曼月乐尾丝宫颈异位1例[J].中国计划生育和妇产科,2019,(7):49.
[7]周怀君.子宫内膜息肉的药物治疗新进展[J].中国计划生育和妇产科,2021,(7):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]
[J].Chinese Journal of Family Planning & Gynecotokology,2021,(02):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]